Neuroendocrinology of neurodegenerative diseases - Insights from transgenic mouse models

被引:16
|
作者
de Aguilar, JLG [1 ]
René, F [1 ]
Dupuis, L [1 ]
Loeffler, JP [1 ]
机构
[1] Univ Strasbourg, Lab Signalisat Mol & Neurodegenerescence, EA 3433, FR-67085 Strasbourg, France
关键词
Alzheimer's disease; neurodegenerative diseases; Parkinson's disease; amyotrophic lateral sclerosis; THYROTROPIN-RELEASING-HORMONE; AMYOTROPHIC-LATERAL-SCLEROSIS; PITUITARY-ADRENAL AXIS; ESTROGEN REPLACEMENT THERAPY; SUPEROXIDE-DISMUTASE GENE; MOTOR-NEURON DISEASE; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; CEREBROSPINAL-FLUID; OXIDATIVE STRESS;
D O I
10.1159/000074445
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The nervous system plays a key role in the regulation of neuroendocrine axes and, in turn, the released neurohormones modulate the activity of different brain regions. Neurodegenerative diseases, which are known to affect specific neuronal populations, may provoke neuroendocrine dysfunctions that alter the intimate relationship between both systems. In addition, these modifications may influence the progression of the neurodegenerative process. In the present review, we summarise some of the endocrine changes characterising three major neurodegenerative diseases: Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. Special attention is focused on the contribution of disease transgenic models to elucidate such alterations. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:244 / 252
页数:9
相关论文
共 50 条
  • [41] Transgenic mouse models for the study of prion diseases
    Marin-Moreno, Alba
    Carlos Espinosa, Juan
    Maria Torres, Juan
    PRIONS AND NEURODEGENERATIVE DISEASES, 2020, 175 : 147 - 177
  • [42] Disruption of Exocytosis in Sympathoadrenal Chromaffin Cells from Mouse Models of Neurodegenerative Diseases
    de Diego, Antonio M. G.
    Ortega-Cruz, Diana
    Garcia, Antonio G.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (06)
  • [43] The value of transgenic and gene targeted models for experimental therapeutics of neurodegenerative diseases
    Price, DL
    Cai, HB
    Savonenko, A
    Borchelt, DR
    Li, T
    Li, W
    Lee, M
    Ma, G
    Wong, PC
    NEUROBIOLOGY OF AGING, 2004, 25 : S21 - S21
  • [44] The value of Transgenic and gene targeted models for experimental therapeutics of neurodegenerative diseases
    Price, DL
    Cai, HB
    Savonenko, A
    Borchelt, DR
    Li, T
    Wong, PC
    JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (11) : 1077 - 1077
  • [45] The value of transgenic and gene targeted models for experimental therapeutics of neurodegenerative diseases
    Price, DL
    Cai, H
    Savonenko, A
    Laird, F
    Borchelt, DR
    Li, T
    MOVEMENT DISORDERS, 2004, 19 : S3 - S3
  • [46] Transgenic mouse models of neurodegenerative disease caused by CAG/polyglutamine expansions
    Bates, GP
    Davies, SW
    MOLECULAR MEDICINE TODAY, 1997, 3 (11): : 508 - 515
  • [47] Transgenic mouse models of neurodegenerative disease: opportunities for therapeutic development.
    Jankowsky J.L.
    Savonenko A.
    Schilling G.
    Wang J.
    Xu G.
    Borchelt D.R.
    Current Neurology and Neuroscience Reports, 2002, 2 (5) : 457 - 464
  • [48] Validity of mouse models for the study of tissue transglutaminase in neurodegenerative diseases
    Bailey, CDC
    Graham, RM
    Nanda, N
    Davies, PJA
    Johnson, GV
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2004, 25 (03) : 493 - 503
  • [49] Synaptic plasticity studies and their applicability in mouse models of neurodegenerative diseases
    Gruart, Agnes
    Madronal, Noelia
    Teresa Jurado-Parras, Maria
    Delgado-Garcia, Jose M.
    TRANSLATIONAL NEUROSCIENCE, 2013, 4 (02) : 134 - 143
  • [50] Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models
    Rivera, Jennifer
    Sobey, Christopher G.
    Walduck, Anna K.
    Drummond, Grant R.
    REDOX REPORT, 2010, 15 (02) : 50 - 63